Psoriatic Arthritis
The Psoriatic Arthritis pipeline: 48 tracked drugs, 38 approved for this indication.
38 approved / phase 46 Phase 32 Phase 22 Phase 1
Compare the share prices of listed companies in Psoriatic Arthritis →
Total attributable cost
$20.3B
$22,272/patient
Drug spend
$12.9B
$14,174/patient
All severities · US
The Psoriatic Arthritis pipeline
Key trial results for every approved and late-stage drug: Psoriatic Arthritis results by drug.